Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
03/2010
03/18/2010WO2010028673A1 Use of a peptide as a therapeutic agent
03/18/2010WO2010028672A1 Use of a peptide as a therapeutic agent
03/18/2010WO2010028671A1 Use of opiorphin as a therapeutic agent
03/18/2010WO2010028655A1 Isoquinolinone derivatives as nk3 antagonists
03/18/2010WO2010028651A2 Method of upregulating sorla for the treatment of alzheimer's disease
03/18/2010WO2010028596A1 The pharmaceutical composition containing ferulic acid and matrine compounds, the preparation and the use thereof
03/18/2010WO2010028419A1 Prevention of psychotic disorders and/or treatment of psychotic symptoms
03/18/2010WO2010011811A3 3-(phenoxyphenylmethyl)pyrrolidine compounds
03/18/2010WO2010010288A3 Alkyl thiazole carbamate derivatives, preparation thereof, and use thereof as faah enzyme inhibitors
03/18/2010WO2010007382A8 Benzazepine derivatives and their use as hstamine h3 antagonists
03/18/2010WO2009156863A3 Substituted tricyclic derivatives against neurodegenerative diseases
03/18/2010WO2009155139A9 Use of isoindoles for the treatment of neurobehavioral disorders
03/18/2010WO2009154697A3 Disc-1 pathway activators in the control of neurogenesis
03/18/2010WO2009152430A3 Methods of treatment of bipolar disorder
03/18/2010WO2009152168A3 Carboxylic acid salts of 2-amino-3-carbethoxyamino-6-(4-fluoro-benzylamino)-pyridine
03/18/2010WO2009146216A3 Antioxidant inflammation modulators: novel derivatives of oleanolic acid
03/18/2010WO2009145996A3 Amide derivatives as positive allosteric modulators and methods of use thereof
03/18/2010WO2009140649A8 Rab3b for the treatment and prevention of parkinson's disease
03/18/2010WO2009132149A3 Treatment of conditions related to cecal ligation shock
03/18/2010WO2009131974A8 Thiophenyl-substituted 2-imino-3-methyl pyrrolo pyrimidinone compounds as bace-1 inhibitors, compositions, and their use
03/18/2010WO2009126931A3 Therapy for bipolar disorder and mania with buprenorphine
03/18/2010WO2009121065A3 Modulation and repletion/enhancement of the complement system for treatment of trauma
03/18/2010WO2009095923A3 Corroles for neuroprotection and neurorescue
03/18/2010US20100071079 Methods for treating autoimmune and chronic inflammatory conditions using antagonists of cd30 or cd30l
03/18/2010US20100069494 Lowering of proteins associated with alzheimer's disease by interrupting gene transcription with a small molecule
03/18/2010US20100069492 Production of ultrapure epa and polar lipids from largely heterotrophic culture
03/18/2010US20100069479 Neurodegenerative disease treatment using jak/stat inhibition
03/18/2010US20100069478 Isoflavone derivatives and uses thereof
03/18/2010US20100069474 Novel coumarin derivatives as ion channel openers
03/18/2010US20100069472 Compositions and their uses directed to huntingtin
03/18/2010US20100069468 Inhibition of beta-amyloid peptide aggregation
03/18/2010US20100069459 Novel forms of [r-(r*,r*)]-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1h-pyrrole-1-heptanoic acid magnesium
03/18/2010US20100069451 Salt of 3-benzyl-2-methyl-2,3,3a,4,5,6,7, 7a- octahydrobenzo[d]isoxazol-4-one
03/18/2010US20100069450 Salt of 3-benzyl-2-methyl-2,3,3a,4,5,6,7, 7a- octahydrobenzo[d]isoxazol-4-one
03/18/2010US20100069444 Phenathrenone compounds, compositons and methods
03/18/2010US20100069443 Compound with benzamide skeleton having cyclooxygenase-1 (cox-1)-selective inhibitory activity
03/18/2010US20100069437 Therapeutic agents useful for treating pain
03/18/2010US20100069432 Bis-Quaternary Ammonium Salts and Methods for Modulating Neuronal Nicotinic Acetylcholine Receptors
03/18/2010US20100069419 Spiropiperidine beta-secretase inhibitors for the treatment of alzheimer's disease
03/18/2010US20100069418 3-heteroaryl (amino or amido)-1-(biphenyl or phenylthiazolyl) carbonylpiperidine derivatives as orexin receptor inhibitors
03/18/2010US20100069416 Azabicyclo [3.1.0] Hexyl Derivatives as Modulators of Dopamine D3 Receptors
03/18/2010US20100069409 "novel compounds"
03/18/2010US20100069406 Aspartyl protease inhibitors
03/18/2010US20100069405 Derivatives of heteroaryl-alkylcarbamates, methods for their preparation and use thereof as fatty acid amido hydrolase enzyme inhibitors
03/18/2010US20100069404 TETRAHYDROCYCLOPENTA[b] INDOLE COMPOUNDS AS ANDROGEN RECEPTOR MODULATORS
03/18/2010US20100069402 Treatment of Behavioral Disorders
03/18/2010US20100069399 Arylpiperazine modulators of d2 receptors, 5-ht1a receptors, and/or 5-ht2a receptors
03/18/2010US20100069396 4-amino-3-(imidazolyl)-pyrazolo[3,4-d]pyrimidines
03/18/2010US20100069394 Fast-dissociating dopamine 2 receptor antagonists
03/18/2010US20100069390 Method of treatment of attention deficit/hyperactivity disorder (ADHD)
03/18/2010US20100069389 Novel forms of reboxetine
03/18/2010US20100069386 Modulators of Hedgehog Signaling Pathways, Compositions and Uses Related Thereto
03/18/2010US20100069384 5-alkyloxy-indolin-2-one derivatives, preparation thereof and application thereof in therapy
03/18/2010US20100069382 Agent for prophylaxis or treatment of alcohol dependence or drug dependence
03/18/2010US20100069381 Gsk-3betainhibitor
03/18/2010US20100069378 Substituted indanyl sulfonamide compounds, their preparation and use as medicaments
03/18/2010US20100069375 Indolone-Acetamide Derivatives, Processes for Preparing Them and Their Uses
03/18/2010US20100069373 Substituted lactams as inhibitors of a beta protein production
03/18/2010US20100069372 Compositions and methods for modulating poly(adp-ribose) polymerase activity
03/18/2010US20100069367 LXR and FXR Modulators
03/18/2010US20100069365 Diazepane-acetamide derivatives as selective 11B-HSD1 inhibitors
03/18/2010US20100069361 Fused Thiazole Derivatives as Kinase Inhibitors
03/18/2010US20100069356 Dibenzothiazepine modulators of dopamine, alpha adrenergic, and serotonin receptors
03/18/2010US20100069354 7-azaindole derivatives and their use in the inhibition of c-jun n-terminal kinase
03/18/2010US20100069349 Novel compounds as cannabinoid receptor ligands
03/18/2010US20100069348 Novel compounds as cannabinoid receptor ligands
03/18/2010US20100069341 Tetrahydro-pyranopyrazole cannabinoid modulators
03/18/2010US20100069337 Butyrylcholinesterase inhibitors
03/18/2010US20100069332 Lipids containing omega-3 and omega-6 fatty acids
03/18/2010US20100069309 Method for medical treatment utilizing glutathione
03/18/2010US20100068315 Composition Comprising an Extract of Gramineae Plant for the Prevention and Treatment of Ischemic Diseases and Degenerative Brain Diseases and the Use Thereof
03/18/2010US20100068308 Regulation of GSK-3alpha activity for the treatment or prevention of Alzheimer's disease
03/18/2010US20100068289 Spherical microcapsules comprising glp-i peptides, their production and use
03/18/2010US20100068270 Bupropion hydrobromide polymorphs
03/18/2010US20100068250 Abuse Potential Reduction in Abusable Substance Dosage Form
03/18/2010US20100068249 Abuse-resistant transdermal dosage form
03/18/2010US20100068231 Therapeutic use of at least one botulinum neurotoxin in the treatment of pain induced by at least one anti-neoplastic agent
03/18/2010US20100068222 Hapten-carrier conjugates for use in drug abuse therapy and methods for preparation of same
03/18/2010US20100068187 Transcription factors for differentiation of adult human olfactory progenitor cells
03/18/2010US20100068177 Methods of organ regeneration
03/18/2010US20100068138 Structurally rigid dopamine d3 receptor selective ligands and process for making them
03/18/2010CA2773031A1 Prevention of psychotic disorders and/or treatment of psychotic symptoms
03/18/2010CA2737388A1 Methods and compositions for modulating ire1, src, and abl activity
03/18/2010CA2736623A1 Use of anti-connexin agents for modulating the therapeutic effect of psychotropic drugs
03/18/2010CA2736559A1 Novel pharmaceutical composition for treating nociceptive pain
03/18/2010CA2736530A1 Piperazine derivatives for binding and imaging amyloid plaques and their use
03/18/2010CA2736250A1 Treatment of pervasive developmental disorders with redox-active therapeutics
03/18/2010CA2736245A1 Methods for the administration of iloperidone
03/18/2010CA2736130A1 Spiro-tetracyclic ring compounds as beta-secretase modulators and methods of use
03/18/2010CA2734309A1 Preparation and usage of a pharmaceutical composition containing ferulic acid and matrine compounds
03/18/2010CA2732612A1 Isoquinolinone derivatives as nk3 antagonists
03/18/2010CA2731660A1 1-amino-alkylcyclohexane derivatives for the treatment of cognitive impairment in tinnitus
03/18/2010CA2699220A1 Use of a peptide as a therapeutic agent
03/17/2010EP2163561A1 NOGO receptor-mediated blockade of axonal growth
03/17/2010EP2163557A1 Function-selective vitamin d receptor agonist
03/17/2010EP2163541A1 Piperazine derivatives for binding and imaging amyloid plaques and their use
03/17/2010EP2163253A1 Extracts from the plant hornstedtia scyphifera and immnunosuppressive effects thereof
03/17/2010EP2163244A1 Agent, pharmaceutical composition, and method for treating the ethyl alcohol and/or narcotic dependence
03/17/2010EP2162141A1 Composition for treating ischemic limb disease comprising stem cells derived from adipose tissue
03/17/2010EP2161998A1 Novel methods
1 ... 493 494 495 496 497 498 499 500 501 502 503 504 505 506 507 508 509 510 511 512 513 ... 1833